CompaniesRanked

2874 companies · fiscal year 2025 · SEC EDGAR · September 25, 2026

Healthcare companies with the most long-term debt — page 2

Ranks 101–200 of 246 · Fiscal year 2025 · Data as of September 25, 2026

Long-term debt
#CompanyLong-term debtYoY15-year trend
101NeogenNEOGUS$793M−10.9%
102Bright Horizons Family SolutionsBFAMUS$748M−18.6%
103Merit Medical SystemsMMSIUS$734M+0.6%
104Integra LifesciencesIARTUS$727M−4.5%
105Sonida Senior LivingSNDAUS$682M+7.3%
106Alnylam PharmaceuticalsALNYUS$676M+253.3%
107Amphastar PharmaceuticalsAMPHUS$620M+1.0%
108Phibro Animal HealthPAHCUS$604M−3.1%
109Edwards LifesciencesEWUS$598M+0.1%
110Biomarin PharmaceuticalBMRNUS$597M—
111ModernaMRNAUS$590M+$590M
112Msa SafetyMSAUS$573M+18.9%
113Emergent BiosolutionsEBSUS$572M−13.8%
114Pediatrix MedicalMDUS$571M−6.7%
115Lantheus HoldingsLNTHUS$569M+0.6%
116Skinhealth SystemsSKINUS$552M—
117RepligenRGENUS$542M+3.2%
118InsmedINSMUS$541M−51.0%
119Curaleaf HoldingsCURLFUS$513M+9.9%
120Alphatec HoldingsATECUS$501M−12.7%
121Sinovac BiotechSVACN$495M+31.7%
122Ascendis PharmaASNDDK$453M+19.4%
123Oscar HealthOSCRUS$430M+43.6%
124Cresco LabsCRLBFUS$417M−9.5%
125ResmedRMDUS$404M−39.1%
126Immunocore HoldingsIMCRGB$403M—
127Telix PharmaceuticalsTLXAU$392M+14.7%
128Porch GroupPRCHUS$385M−4.6%
129Supernus PharmaceuticalsSUPNUS$379M+1,532.9%
130Caris Life SciencesCAIUS$379M+18.6%
131Idexx LaboratoriesIDXXUS$375M−16.7%
132Pacira BiosciencesPCRXUS$372M−3.0%
133MannkindMNKDUS$355M+883.7%
134LivanovaLIVNGB$345M−37.2%
135Madrigal PharmaceuticalsMDGLUS$340M+189.1%
136Alignment HealthcareALHCUS$323M+0.5%
137Tandem Diabetes CareTNDMUS$310M+0.6%
138Ani PharmaceuticalsANIPUS$292M−5.6%
139Ascend WellnessAAWHUS$291M+35.8%
140Cadre HoldingsCDREUS$291M+37.4%
141Indivior PharmaceuticalsINDVUS$290M−7.9%
142Maravai LifesciencesMRVIUS$286M−1.4%
143PTC TherapeuticsPTCTUS$285M+0.4%
144NateraNTRAUS$283M+0.5%
145BioventusBVSUS$279M−9.5%
146Lifestance HealthLFSTUS$266M−5.0%
147Bio-TechneTECHUS$260M−13.3%
148InnovivaINVAUS$258M+0.6%
149HarrowHROWUS$250M−4.8%
150Establishment LabsESTAVG$248M+12.7%
151TG TherapeuticsTGTXUS$246M+0.5%
152Pacs GroupPACSUS$245M−2.5%
153NovavaxNVAXUS$244M—
154P3 Health PartnersPIIIUS$228M+109.7%
155National VisionEYEUS$223M−6.7%
156Xeris BiopharmaXERSUS$220M+1.5%
157ArtivionAORTUS$215M−31.5%
158Phathom PharmaceuticalsPHATUS$209M+3.8%
159Nu Skin EnterprisesNUSUS$204M−43.8%
160ArdelyxARDXUS$203M+34.5%
161West Pharmaceutical ServicesWSTUS$203M+0.1%
162Jushi HoldingsJUSHUS$199M+8.6%
163Ironwood PharmaceuticalsIRWDUS$199M−50.0%
164NovocureNVCR$195M+100.5%
165BiontechBNTXDE$194M−31.4%
166ValnevaVALNFR$189M+9.5%
167Karyopharm TherapeuticsKPTIUS$169M—
168Pennant GroupPNTGUS$169M+$169M
169Canopy GrowthCGCCA$164M−46.1%
170Orthofix MedicalOFIXUS$157M+0.2%
171U S Physical TherapyUSPHUS$153M+7.1%
172Tilray BrandsTLRYUS$152M+1,509.6%
173EvolusEOLSUS$146M+20.2%
174Harmony BiosciencesHRMYUS$144M−11.9%
175Ensign GroupENSGUS$138M−2.9%
176Trulieve CannabisTRLVUS$137M−62.5%
177Adaptive BiotechnologiesADPTUS$127M−4.4%
178AccurayARAYUS$125M−25.7%
179Ufp TechnologiesUFPTUS$123M−30.5%
180Addus HomecareADUSUS$121M−44.6%
181Myriad GeneticsMYGNUS$120M+202.8%
182Axsome TherapeuticsAXSMUS$118M−34.8%
183Arcutis BiotherapeuticsARQTUS$108M+0.7%
184TrupanionTRUPUS$102M−20.2%
185Rhythm PharmaceuticalsRYTMUS$101M−6.8%
186OrthopediatricsKIDSUS$99.8M+36.8%
187Arcus BiosciencesRCUSUS$99.0M+106.3%
188BioteBTMDUS$95.8M−5.4%
189ChemedCHEUS$92.5M−50.0%
190Avanos MedicalAVNSUS$90.3M−27.9%
191Starling OncologySTLNUS$77.4M−16.9%
192XencorXNCRUS$76.5M−33.6%
193MarimedMRMDUS$76.0M−2.7%
194NRC HealthNRCUS$75.0M+29.6%
195Tarsus PharmaceuticalsTARSUS$72.4M+0.8%
196Adma BiologicsADMAUS$69.3M−4.2%
197Glass House BrandsGLASUS$68.6M+35.8%
198HUTCHMED (China)HCMHK$68.2M+14.7%
199Organogenesis HoldingsORGOUS$66.6M−6.6%
200NeuroneticsSTIMUS$65.8M+19.3%

All figures from SEC filings · FY2025 · 100

see sources

Download this data as a CSV →

Companies with the most long-term debt →

By sector

By country